Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant

Clinical trial NCT04312789 · WITHDRAWN

Trial details

NCT number: NCT04312789
Sponsor: Ayman Saad
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Platelet Disorder

Start date: 2022-12-01
Primary completion: 2022-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.